NeuBase Therapeutics, Inc. Share-based Payment Arrangement, Expense
NeuBase Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of -$292.34 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-11-09
- NeuBase Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2023-09-30 was -$292.34K, a 157.25% decline year-over-year.
- NeuBase Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2023-06-30 was $245.01K, a 61.78% decline year-over-year.
- NeuBase Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2023-03-31 was $316.69K, a 66.76% decline year-over-year.
- NeuBase Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2022-12-31 was -$509.07K, a 164.18% decline year-over-year.
- NeuBase Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $2.90M, a 21.61% decline from fiscal 2021.
- NeuBase Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2021 was $3.70M, a 28.84% decline from fiscal 2020.
- NeuBase Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2020 was $5.19M, a 42.02% decline from fiscal 2019.
- NeuBase Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2019 was $8.96M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | -$292.34K 10-Q · filed 2023-11-09 | -$47.33K derived: sum of 2 quarters · filed 2023-11-09 | $269.36K 10-Q · filed 2023-11-09 | -$239.71K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2023-06-30 | $245.01K 10-Q · filed 2023-08-14 | $561.70K 10-Q · filed 2023-08-14 | $52.63K derived: sum of 3 quarters · filed 2023-08-14 | $563.24K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2023-03-31 | $316.69K 10-Q · filed 2023-05-11 | -$192.38K derived: sum of 2 quarters · filed 2023-06-05 | $318.23K derived: sum of 3 quarters · filed 2023-11-09 | $959.27K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-12-31 | -$509.07K 10-QT · filed 2023-06-05 | $1.54K derived: sum of 2 quarters · filed 2023-11-09 | $642.59K derived: sum of 3 quarters · filed 2023-11-09 | $1.60M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-09-30 | $510.61K 10-Q · filed 2023-11-09 | $1.15M derived: sum of 2 quarters · filed 2023-11-09 | $2.10M 10-Q · filed 2023-11-09 | $2.90M 10-K · filed 2022-12-21 | |
| 2022-06-30 | $641.05K 10-Q · filed 2023-08-14 | $1.59M 10-Q · filed 2023-08-14 | $2.39M 10-Q · filed 2022-08-11 | $3.34M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $952.83K 10-Q · filed 2023-05-11 | $1.75M 10-Q · filed 2022-05-12 | $2.70M derived: sum of 3 quarters · filed 2023-06-05 | $3.32M derived: sum of 4 quarters · filed 2023-06-05 | |
| 2021-12-31 | $793.20K 10-QT · filed 2023-06-05 | $1.75M derived: sum of 2 quarters · filed 2023-06-05 | $2.37M derived: sum of 3 quarters · filed 2023-06-05 | $3.31M derived: sum of 4 quarters · filed 2023-06-05 | |
| 2021-09-30 | $952.51K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-21 | $1.58M derived: sum of 2 quarters · filed 2022-12-21 | $2.52M derived: sum of 3 quarters · filed 2022-12-21 | $3.70M 10-K · filed 2022-12-21 | |
| 2021-06-30 | $625.18K 10-Q · filed 2022-08-11 | $1.57M derived: sum of 2 quarters · filed 2022-08-11 | $2.74M 10-Q · filed 2022-08-11 | $3.88M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $942.11K 10-Q · filed 2022-05-12 | $2.12M 10-Q · filed 2022-05-12 | $3.26M derived: sum of 3 quarters · filed 2022-05-12 | $4.47M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $1.18M 10-Q · filed 2022-02-11 | $2.32M derived: sum of 2 quarters · filed 2022-02-11 | $3.53M derived: sum of 3 quarters · filed 2022-02-11 | $4.87M derived: sum of 4 quarters · filed 2022-02-11 | |
| 2020-09-30 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-23 | $2.35M derived: sum of 2 quarters · filed 2021-12-23 | $3.69M derived: sum of 3 quarters · filed 2021-12-23 | $5.19M 10-K · filed 2021-12-23 | |
| 2020-06-30 | $1.21M 10-Q · filed 2021-08-13 | $2.55M derived: sum of 2 quarters · filed 2021-08-13 | $4.05M 10-Q · filed 2021-08-13 | $10.65M derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $1.34M 10-Q · filed 2021-05-14 | $2.84M 10-Q · filed 2021-05-14 | $9.44M derived: sum of 3 quarters · filed 2021-05-14 | $10.26M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $1.50M 10-Q · filed 2021-02-11 | $8.10M derived: sum of 2 quarters · filed 2021-02-11 | $8.92M derived: sum of 3 quarters · filed 2021-02-11 | $10.17M derived: sum of 4 quarters · filed 2021-02-11 | |
| 2019-09-30 | $6.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | $7.41M derived: sum of 2 quarters · filed 2020-12-23 | $8.67M derived: sum of 3 quarters · filed 2020-12-23 | $8.96M 10-K · filed 2020-12-23 | $9.79M 10-K · filed 2020-01-10 |
| 2019-06-30 | $819.57K 10-Q · filed 2020-08-13 | $2.07M derived: sum of 2 quarters · filed 2020-08-13 | $2.37M 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $1.25M 10-Q · filed 2020-05-14 | $1.55M 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $293.30K 10-Q · filed 2020-03-26 | ||||
| 2016-06-30 | $610.82K 10-Q · filed 2016-08-09 | $2.02M derived: sum of 2 quarters · filed 2016-08-09 | $2.34M 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | $1.41M 10-Q · filed 2016-05-10 | $1.72M 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | $316.82K 10-Q · filed 2016-02-09 |